INNATE PHARMA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.245 EUR | +2.98% |
|
+6.40% | -14.31% |
| Apr. 15 | Sanofi: progress in hematology trial | CF |
| Apr. 15 | Innate Pharma: progress in hematology trial | CF |
Quotes 5-day view
Real-time Euronext Paris| 2024-04-22 | 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|---|
| Last | 2.165 € | 2.26 € | 2.235 € | 2.18 € | 2.245 € |
| Volume | 34 564 | 79 753 | 60 896 | 19 133 | 23 486 |
| Change | +2.61% | +4.39% | -1.11% | -2.46% | +2.98% |
| Opening | 2.11 | 2.19 | 2.25 | 2.24 | 2.23 |
| High | 2.19 | 2.27 | 2.26 | 2.25 | 2.245 |
| Low | 2.11 | 2.16 | 2.20 | 2.18 | 2.2 |
Performance
| 1 day | +2.98% | ||
| 1 week | +6.40% | ||
| Current month | +2.75% | ||
| 1 month | +2.28% | ||
| 3 months | -10.74% | ||
| 6 months | -4.06% | ||
| Current year | -14.31% | ||
| 1 year | -15.60% | ||
| 3 years | -35.45% | ||
| 5 years | -61.09% | ||
| 10 years | -64.59% |
Volumes
marketsDaily volume
23 486
Estimated daily volume
77 114
Avg. Volume 20 sessions
63 188
Daily volume ratio
1.22
Avg. Volume 20 sessions
141 857.06
Avg. Volume 20 sessions USD
152 337.46
Record volume 1
14 161 860
Record volume 2
10 742 570
Record volume 3
9 928 481
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
175 801 834
Capitalization (USD)
188 790 073
Net sales (EUR)
61 641 000
Net sales (USD)
66 195 037
Number of employees
179
Sales / Employee (EUR)
344 363
Sales / Employee (USD)
369 805
Free-Float
74.91 %
Free-Float capitalization (EUR)
131 727 471
Free-Float capitalization (USD)
141 459 497
Average Daily Capital Traded
0.08%
Highs and lows
1 week
2.11
2.27
1 month
2.112.39
Current year
2.112.80
1 year
2.113.35
3 years
1.998.30
5 years
1.998.30
10 years
1.9917.85
Indicators
Moving average 5 days
2.19
Moving average 20 days
2.24
Moving average 50 days
2.25
Moving average 100 days
2.35
Price spread / (MMA5)
-2.45%
Price spread / (MMA20)
-0.40%
Price spread / (MMA50)
+0.24%
Price spread / (MMA100)
+4.46%
STIM
RSI 9 days
51.63
RSI 14 days
50.09
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +2.98% | +6.40% | -14.31% | -15.60% | 189M | ||
| -2.85% | +3.00% | +1.12% | +22.05% | 42.59B | ||
| -2.45% | +4.10% | +6.77% | -21.29% | 40.65B | ||
| +1.65% | +3.86% | +47.64% | -4.36% | 40.57B | ||
| -1.17% | +0.17% | -11.96% | +7.26% | 26.77B | ||
| -3.02% | +2.83% | +6.01% | +47.66% | 24.81B | ||
| -0.06% | -1.00% | -24.92% | -28.91% | 18.17B | ||
| -4.85% | +0.11% | -3.63% | +21.43% | 11.7B | ||
| -1.96% | +4.13% | +27.16% | +87.15% | 12.05B | ||
| -0.44% | -0.41% | +7.30% | +4.26% | 11.1B | ||
| -1.35% | +0.72% | -18.79% | -20.41% | 9.85B | ||
| -1.06% | +4.08% | -8.25% | -9.72% | 9.09B | ||
| +0.63% | +1.46% | +22.77% | -15.47% | 6.56B | ||
| -1.44% | +2.52% | -17.30% | +16.61% | 6.1B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| +0.78% | +2.47% | -3.57% | -41.85% | 5.92B | ||
| Average | -0.91% | +2.08% | +1.07% | +3.25% | ||
| Weighted average by Cap. | -1.35% | +2.21% | +6.60% | +5.85% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
422c503acacb53f4a0d0728bfa94.2yeLpE-etv_HYzfq9FrSF1Zb4uyVCPqfkJ2eKHXCY1E.gVD99CWo4oz2VH-TmTyoLxwViq7QUMv53s_QfQSoBxysErL2BebVq_8GRA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 05:31:19 am | 2.245 | 214 | 23,486 |
| 05:14:21 am | 2.24 | 46 | 23,272 |
| 05:14:21 am | 2.24 | 233 | 23,226 |
| 05:12:52 am | 2.24 | 223 | 22,993 |
| 05:11:29 am | 2.24 | 400 | 22,770 |
| 05:10:31 am | 2.24 | 694 | 22,370 |
| 05:06:50 am | 2.24 | 106 | 21,676 |
| 05:06:50 am | 2.23 | 656 | 21,570 |
| 05:06:50 am | 2.23 | 613 | 20,914 |
| 05:04:05 am | 2.23 | 23 | 20,301 |
Monthly variations
Annual change
| 2024 | -16.79% | ||
| 2023 | -20.36% | ||
| 2022 | -26.03% | ||
| 2021 | +28.48% | ||
| 2020 | -41.91% | ||
| 2019 | -19.84% | ||
| 2018 | +56.53% | ||
| 2017 | -67.49% | ||
| 2016 | +7.90% | ||
| 2015 | +71.39% | ||
| 2014 | +59.27% | ||
| 2013 | +128.57% | ||
| 2012 | +58.39% | ||
| 2011 | +17.09% | ||
| 2010 | -51.45% | ||
| 2009 | +74.64% | ||
| 2008 | -62.19% | ||
| 2007 | -41.60% | ||
| 2006 | +29.40% |
- Stock Market
- Equities
- IPH Stock
- Quotes Innate Pharma
